Skip Navigation

Uncertainty around medicinal cannabis

The Department of Health is still ambiguous on how it intends to change existing legislation to allow for the prescription of cannabis-based medicinal products in Ireland.

Although the European Medicines  Agency has given the cannabis-based drug Sativex a “recommended for approval”  status in Ireland under its Mutual Recognition Procedure, cannabis cannot be prescribed by physicians until it is reclassified under the Misuse of Drugs Regulations 1988.
The Irish Cancer Society, Chronic Pain Ireland and MS Ireland have all welcomed the possibility of HTA approved cannabis-based medicines becoming available in Irish medical practice.
Currently, cannabis is considered a Schedule I substance through the Misuse of Drugs Regulations 1988, and is thus more restricted than Schedule II substances which include medicinal opium, methadone, cocaine and heroin.
In 2010, Health Minister James Reilly, then an Opposition TD, asked former Health Minister Mary Harney if she “would ensure that Sativex is made available to multiple sclerosis (MS) sufferers here”. The Department has not yet amended existing legislation to allow for the prescription of approved cannabis-based medicinal products.

Read more...

Source: Florian Scheibein, Irish Medical News, 16/07/12

Posted by drugsdotie on 07/16 at 02:03 PM in
Share this:
  • Facebook
  • Twitter
  • Digg
  • Del.icio.us
  • LinkedIn
  • E-mail
(1) Comments

Comments

#1. Posted by focusonpeace on July 21, 2012

Cannabis based? Why not just actual cannabis?

Name:

Email:

URL:

Comments:

Remember my personal information

Notify me of follow-up comments?

Enter this word:


Here:

Our online 'Live Help' chat service offers you a person to talk to.
This is a free, secure and confidential online chat service - your identity is not made known to the staff member.

Click the button below to launch the chat service.
Live Helper
NewslettereBulletin
Poll Poll

Should the Government introduce plain packaging for cigarettes?